Необязательная аналитика продукта
С вашего разрешения мы используем ограниченную аналитику с защитой конфиденциальности, чтобы понять, какие исследовательские сценарии работают. Мы не используем рекламные трекеры или запись сеансов. Этот выбор можно изменить в настройках. Прочитайте Политику конфиденциальности.
Synopsys Inc.'s published Reduce conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $86.4B | |
|---|---|---|
| Revenue (ttm) | 9.4B | |
| Net income (ttm) | 1.1B | |
| EPS (ttm) | $5.64 | |
| Shares out | 191.6M | |
| P/E (trailing) | 85.4x | |
| P/E (forward) | 23.3x | |
| Volume | 1,607,943 | |
| Beta | 1.21 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | Trend |
| Revenue | $4.20B | $4.62B | $5.32B | $6.13B | $7.05B | +13.8% |
| Gross profit | $3.34B | $3.72B | $4.29B | $4.88B | $5.43B | +12.9% |
| Operating income | $734.8M | $1.15B | $1.27B | $1.36B | $914.9M | +5.6% |
| Net income | $757.5M | $984.6M | $1.23B | $2.26B | $1.33B | +15.2% |
| EPS (diluted) | $4.81 | $6.29 | $7.92 | $14.51 | $8.04 | +13.7% |
| EBITDA | $1.01B | $1.33B | $1.56B | $1.85B | $2.50B | +25.4% |
| R&D | $1.50B | $1.59B | $1.85B | $2.08B | $2.48B | +13.3% |
| SG&A | $323.0M | $313.6M | $376.7M | $568.5M | $769.6M | +24.2% |
Recent company headlines from major financial publishers.
The modal base case reflects steady execution of the core EDA duopoly and successful baseline integration of Ansys. Revenue expands from $7.05B in FY2025 to $9.72B in FY2026 (including $2.98B from Ansys), and reaches $11.03B in FY2027. Normalized operating margin expands steadily from 25.5% in FY2026 to 32.5% by FY2030. Discounted at a 10.12% cost of equity and 9.82% WACC, the synthesized fair value midpoint is $382.30.
In the upside scenario, explosive customer adoption of agentic AI engineering workflows and doubling of die-to-die chiplet IP design wins drive accelerated top-line expansion. Joint solutions with Ansys deliver faster-than-expected cross-selling synergies in 3DIC advanced packaging, while rapid deleveraging lowers the cost of capital. Five-year EPS growth averages 21.0%, supporting the upper boundary of our valuation framework.
| Ke ↓ / g → | 2.5% | 3.0% | 3.5% | 4.0% | 4.5% |
|---|---|---|---|---|---|
| 9.1% | $397 | $407 | $420 | $434 | $452 |
| 9.6% | $381 | $390 | $400 | $412 | $426 |
| 10.1% | $366 | $374 | $382 | $392 | $404 |
| 10.6% | $353 | $360 | $367 | $375 | $385 |
| 11.1% | $341 | $347 | $353 | $360 | $368 |
Upcoming earnings date and setup when available.
Рейтинг, который имело опубликованное в каждом месяце издание исследования. Рейтинг сравнивает цену на дату анализа со справедливой стоимостью; он не показывает, оправдалась ли оценка.
| Год | янв. | февр. | март | апр. | май | июнь | июль | авг. | сент. | окт. | нояб. | дек. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |